Use of AlignRT System During Stereotactic Radiosurgery
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
This was a prospective, single-group clinical study conducted at the Institute of Oncology Ljubljana. The study included adult patients with brain metastases who were scheduled to receive single-fraction stereotactic radiosurgery using the TrueBeam STx linear accelerator.
Each participant underwent two positioning procedures before treatment. Standard manual positioning was performed using the delta couch shift function, followed by partial CBCT verification. The participant was then positioned automatically using the AlignRT surface-guided radiotherapy system, followed by a second partial CBCT verification.
Residual positioning deviations were recorded in three translational directions (vertical, longitudinal, and lateral) and three rotational directions (rotation, pitch, and roll). The average deviations obtained after manual positioning were compared with those obtained after AlignRT-guided positioning. Additional analyses considered participant age and sex. Positioning data were obtained from the ARIA information system and analyzed using Microsoft Excel and IBM SPSS.
A total of 20 participants completed the study. No additional follow-up was required after completion of the positioning measurements.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- Institute of Oncology Ljubljana
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 years or older
- Patients with brain metastases eligible for single-fraction stereotactic radiosurgery
- Treatment performed using the TrueBeam STx linear accelerator
- Able and willing to provide written informed consent.
Exclusion Criteria:
- Patients younger than 18 years
- Patients receiving fractionated stereotactic radiotherapy
- Treatment performed using a linear accelerator other than TrueBeam STx.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Manual and AlignRT-Guided Positioning
Participants underwent standard manual positioning followed by automatic positioning using the AlignRT system before stereotactic radiosurgery.
A partial cone-beam computed tomography scan was performed after each positioning method to measure residual translational and rotational setup deviations.
|
Participants were manually positioned from the initial setup position to the treatment isocenter using the delta couch shift function.
A partial cone-beam computed tomography scan was then performed to measure residual setup deviations in three translational and three rotational directions.
Participants were automatically positioned at the treatment isocenter using the AlignRT surface-guided radiotherapy system.
A partial cone-beam computed tomography scan was then performed to measure residual setup deviations in three translational and three rotational directions.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Residual Translational Setup Deviations After Manual and AlignRT-Guided Positioning
Time Frame: Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
Residual setup deviations measured by partial cone-beam computed tomography in the vertical, longitudinal, and lateral directions, expressed in centimeters.
Mean deviations were compared between manual positioning and AlignRT-guided positioning within the same participants.
|
Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
|
Residual Rotational Setup Deviations After Manual and AlignRT-Guided Positioning
Time Frame: Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
Residual setup deviations measured by partial cone-beam computed tomography for rotation, pitch, and roll, expressed in degrees.
Mean deviations were compared between manual positioning and AlignRT-guided positioning within the same participants.
|
Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in Absolute Translational Setup Deviations Between AlignRT-Guided and Manual Positioning
Time Frame: Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
Within-participant comparison of the absolute residual setup deviations measured in the vertical, longitudinal, and lateral directions after AlignRT-guided positioning and manual positioning.
Deviations were expressed in centimeters.
Smaller absolute deviations indicate greater positioning accuracy.
|
Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
|
Difference in Absolute Rotational Setup Deviations Between AlignRT-Guided and Manual Positioning
Time Frame: Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
Within-participant comparison of the absolute residual setup deviations measured for rotation, pitch, and roll after AlignRT-guided positioning and manual positioning.
Deviations were expressed in degrees.
Smaller absolute deviations indicate greater positioning accuracy.
|
Immediately after each positioning procedure and before stereotactic radiosurgery, during the same treatment visit.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Klemen Salmič, MSc, Institute of Oncology Ljubljana
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ERIDNPVO-0017/2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.